The ESCMID Study Group for Respiratory Viruses (ESGREV) is at the forefront of respiratory virus research and medicine. Uniting experts on a global scale, they are committed to:
Long COVID: Pathophysiology, current concepts, and future directions.
Skevaki C, Moschopoulos CD, Fragkou PC, Grote K, Schieffer E, Schieffer B. J Allergy Clin Immunol. 2024 Dec 24:S0091-6749(24)02406-0
Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis.
Dallmeyer LK, Schüz ML, Fragkou PC, Omony J, Krumbein H, Dimopoulou D, Dimopoulou K, Skevaki C. Int J Infect Dis. 2024 Jan;138:10-18.
Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line?
Sassine J, Hirsch HH, Chemaly RF; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Clin Microbiol Infect. 2024 Mar;30(3):270-275.
Effects of long-term corticosteroid use on susceptibility to respiratory viruses: a narrative review.
Fragkou PC, Dimopoulou D, Moschopoulos CD, Skevaki C; ESCMID Study Group for Respiratory Viruses (ESGREV). Clin Microbiol Infect. 2024 Sep 25:S1198-743X(24)00446-4.
Infections in immunocompromised hosts: progress made and challenges ahead.
Sassine J, Skevaki C, Chemaly RF; European Society for Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Clin Microbiol Infect. 2024 Oct 22:S1198-743X(24)00499-3
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Azuly H, Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Infect Dis Ther. 2024
Disease Burden and Inpatient Management of Children with Acute Respiratory Viral Infections during the Pre-COVID Era in Germany: A Cost-of-Illness Study.
Alchikh M, Conrad TOF, Obermeier PE, Ma X, Schweiger B, Opota O, Rath BA. Viruses. 2024 Mar 26;16(4):507
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos-Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Cancer Med. 2024 Feb;13(3):e6997
American Society of Transplantation and Cellular Therapy series: #7 – Management of respiratory syncytial virus infections in hematopoietic cell transplant recipients.
El Chaer F, Kaul DR, Englund JA, Boeckh M, Batista MV, Seo SK, Carpenter PA, Navarro D, Hirsch HH, Ison MG, Papanicolaou GA, Chemaly RF. Transplant Cell Ther. 2023;29(12):730–738.
Disease burden and inpatient management of children with acute respiratory viral infections during the pre-COVID era in Germany: a cost-of-illness study. (PrePrint)
Alchikh M, Conrad TOF, Obermeier PE, Ma X, Schweiger B, Opota O, Rath BA. Viruses. 2023110966. Preprint.
Epidemiology of respiratory viruses among children during the SARS-CoV-2 pandemic: A systematic review and meta-analysis.
Dallmeyer L, Schuz ML, Fragkou PC, Omony J, Krumbein H, Dimopoulou D, Skevaki C. Int J Infect Dis. 2024;138:10–18.
Immune response to respiratory viruses and respiratory viral infections in susceptible populations.
Fragkou PC, Dimopoulou D, De Angelis G, Menchienelli G, Chemaly RF, Skevaki C, On behalf of the European Society of Clinical Microbiology Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Front Med (Lausanne). 2023;10:1330265.
Clinical trials for treatment of respiratory viral infections in recipients of haematopoietic cell transplantation and cellular therapies: are we on the right path to the finish line?
Sassine J, Hirsch HH, Chemaly RF. Clin Microbiol Infect. 2024;30(3):270–275.
An international multi-center study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with Obinutuzumab vs. Rituximab.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh‐Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos‐Ramos JC, Chowers M, Rogozin E, Oren NC, Keske S, Barchad OW, Nesher L, and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Cancer Medicine. 2024;13(3):e6997.
ESGREV/ESGEM: The use of saliva for surveillance of respiratory viruses
If you have questions or comments for our study group, we warmly invite you to contact us!
